Ananda Pharma Completes Phase 1 Study of MRX1 Cann...
Category : Clinical Trial Update 19 June 2026Ananda Pharma Reports Positive Phase 1 Results for MRX1 UK-based Ananda Pharma has announced the...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Bayer Completes Acquisition of Perfuse Therapeutic...
Category : Merger/Acquisition 19 June 2026Bayer Finalizes Perfuse Therapeutics Acquisition Bayer has announced the successful completion of i...
Dimerix Partners with Everest Medicines to Expand...
Category : Licensing/Collaboration Deal 18 June 2026Australian clinical-stage biopharmaceutical company Dimerix Limited has entered into an exclusive li...
Gesynta Pharma Reaches Key Recruitment Milestone i...
Category : Clinical Trial Update 18 June 2026Gesynta Pharma AB, a Swedish clinical-stage pharmaceutical company focused on chronic inflammatory d...
Lundbeck Reports Encouraging Phase II Results for...
Category : Clinical Trial Update 17 June 2026Lundbeck Shares New Clinical Data at ENDO 2026 Biopharmaceutical company Lundbeck has announced p...
Latest Newsletter Post
-
Bayer Completes Acquisition of Perf..
19 June 2026
-
Ananda Pharma Completes Phase 1 Stu..
19 June 2026
-
Gesynta Pharma Reaches Key Recruitm..
18 June 2026
-
Dimerix Partners with Everest Medic..
18 June 2026
-
Istesso Begins Phase 2 Trial of Ler..
17 June 2026
